Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Jan 1;177(1):127–134. doi: 10.1084/jem.177.1.127

Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains

PMCID: PMC2190873  PMID: 7678109

Abstract

B and T cell responses of several strains of mice, immunized with a monoclonal antiidiotype (anti-Id) that mimics the a determinant of hepatitis B surface antigen (HBsAg), were studied to determine if the immune response to the anti-Id was regulated by H-2-linked immune response genes as has been previously observed for HBsAg. We report that immunization with anti-Id could elicit HBsAg-specific antibodies in mice of the H-2d,q, or f haplotype and in an outbred wild mouse strain (Mus spretus), thus circumventing the H-2 haplotype restriction pattern observed when immunizing with HBsAg in H-2f mice. Purified lymph node T cells from mice of the H-2d or q haplotype and M. spretus that were primed in vivo with HBsAg or anti-Id could be stimulated in vitro with either HBsAg or anti-Id but not with an irrelevant antibody of the same subclass as the anti-Id. However, purified lymph node T cells from H-2f mice that were primed in vivo with the anti-Id could only be stimulated in vitro with anti-Id. No in vitro stimulation whatsoever was observed in H-2f mice immunized with HBsAg. The effect of processing and presentation of the anti-Id by antigen-presenting cells (APC) was studied in mice of the H-2d haplotype. Stimulation of purified lymph node T cells by HBsAg and anti-Id was shown to be strictly dependent on APC and restricted by major histocompatibility complex class II antigens at the I-A locus. Treatment of APC with paraformaldehyde or chloroquine abrogated the T cell response to all antigens except for a nine-amino acid synthetic peptide representing a partial analogue of the group a determinant of HBsAg S(139-147). The significance of these results is discussed in the context of understanding the mechanism of mimicry elicited by the anti-Id.

Full Text

The Full Text of this article is available as a PDF (798.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Kruskall M. S., Marcus-Bagley D., Craven D. E., Katz A. J., Brink S. J., Dienstag J. L., Awdeh Z., Yunis E. J. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989 Sep 14;321(11):708–712. doi: 10.1056/NEJM198909143211103. [DOI] [PubMed] [Google Scholar]
  2. Bhatnagar P. K., Papas E., Blum H. E., Milich D. R., Nitecki D., Karels M. J., Vyas G. N. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4400–4404. doi: 10.1073/pnas.79.14.4400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. De Kruyff R. H., Ju S. T., Laning J., Dorf M. E. Analysis of T cell responses to poly-L(GluLys) at the clonal level. I. Presence of responsive clones in nonresponder mice. Eur J Immunol. 1987 Aug;17(8):1115–1120. doi: 10.1002/eji.1830170807. [DOI] [PubMed] [Google Scholar]
  4. Egea E., Iglesias A., Salazar M., Morimoto C., Kruskall M. S., Awdeh Z., Schlossman S. F., Alper C. A., Yunis E. J. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med. 1991 Mar 1;173(3):531–538. doi: 10.1084/jem.173.3.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eichmann K., Emmrich F., Kaufmann S. H. Idiotypic vaccinations: consideration towards a practical application. Crit Rev Immunol. 1987;7(3):193–227. [PubMed] [Google Scholar]
  6. Graham C. M., Barnett B. C., Hartlmayr I., Burt D. S., Faulkes R., Skehel J. J., Thomas D. B. The structural requirements for class II (I-Ad)-restricted T cell recognition of influenza hemagglutinin: B cell epitopes define T cell epitopes. Eur J Immunol. 1989 Mar;19(3):523–528. doi: 10.1002/eji.1830190317. [DOI] [PubMed] [Google Scholar]
  7. Kovac Z., Schwartz R. H. The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation. J Immunol. 1985 May;134(5):3233–3240. [PubMed] [Google Scholar]
  8. Kruskall M. S., Alper C. A., Awdeh Z., Yunis E. J., Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med. 1992 Feb 1;175(2):495–502. doi: 10.1084/jem.175.2.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Landegren U., Andersson J., Wigzell H. Mechanism of T lymphocyte activation by OKT3 antibodies. A general model for T cell induction. Eur J Immunol. 1984 Apr;14(4):325–328. doi: 10.1002/eji.1830140409. [DOI] [PubMed] [Google Scholar]
  10. Milich D. R., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 1982 Jul;129(1):320–325. [PubMed] [Google Scholar]
  11. Milich D. R. Genetic and molecular basis for T- and B-cell recognition of hepatitis B viral antigens. Immunol Rev. 1987 Oct;99:71–103. doi: 10.1111/j.1600-065x.1987.tb01173.x. [DOI] [PubMed] [Google Scholar]
  12. Milich D. R., Louie R. E., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions. J Immunol. 1985 Jun;134(6):4194–4202. [PubMed] [Google Scholar]
  13. Milich D. R., McLachlan A., Chisari F. V., Kent S. B., Thorton G. B. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. J Immunol. 1986 Jul 1;137(1):315–322. [PubMed] [Google Scholar]
  14. Milich D. R., Peterson D. L., Leroux-Roels G. G., Lerner R. A., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity. J Immunol. 1985 Jun;134(6):4203–4211. [PubMed] [Google Scholar]
  15. Neurath A. R., Pride M. W., Strick N., Thanavala Y. M. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147). Pept Res. 1990 May-Jun;3(3):116–122. [PubMed] [Google Scholar]
  16. Pride M. W., Shi H., Anchin J. M., Linthicum D. S., LoVerde P. T., Thakur A., Thanavala Y. Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11900–11904. doi: 10.1073/pnas.89.24.11900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rees A. D., Praputpittaya K., Scoging A., Dobson N., Ivanyi J., Young D., Lamb J. R. T-cell activation by anti-idiotypic antibody: evidence for the internal image. Immunology. 1987 Mar;60(3):389–393. [PMC free article] [PubMed] [Google Scholar]
  18. Rees A. D., Scoging A., Dobson N., Praputpittaya K., Young D., Ivanyi J., Lamb J. R. T cell activation by anti-idiotypic antibody: mechanism of interaction with antigen-reactive T cells. Eur J Immunol. 1987 Feb;17(2):197–201. doi: 10.1002/eji.1830170208. [DOI] [PubMed] [Google Scholar]
  19. Roberts I. M., Bernard C. C., Vyas G. N., Mackay I. R. T-cell dependence of immune response to hepatitis B antigen in mice. Nature. 1975 Apr 17;254(5501):606–607. doi: 10.1038/254606a0. [DOI] [PubMed] [Google Scholar]
  20. Sharpe A. H., Gaulton G. N., McDade K. K., Fields B. N., Greene M. I. Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med. 1984 Oct 1;160(4):1195–1205. doi: 10.1084/jem.160.4.1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Alter H. J., Taylor P. E., DeVera A., Chen G. T., Kellner A. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med. 1982 Dec 9;307(24):1481–1486. doi: 10.1056/NEJM198212093072403. [DOI] [PubMed] [Google Scholar]
  22. Tedder R. S., Guarascio P., Yao J. L., Lord R. B., Eddleston A. L. Production of monoclonal antibodies to hepatitis B surface and core antigens, and use in the detection of viral antigens in liver biopsies. J Hyg (Lond) 1983 Feb;90(1):135–142. doi: 10.1017/s0022172400063932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thanavala Y. M., Bond A., Hay F. C., Roitt I. M. Immunofluorescent technique for the detection of monoclonal internal image anti-idiotypic antibodies of hepatitis B surface antigen. J Immunol Methods. 1985 Nov 7;83(2):227–232. doi: 10.1016/0022-1759(85)90244-3. [DOI] [PubMed] [Google Scholar]
  24. Thanavala Y. M., Bond A., Tedder R., Hay F. C., Roitt I. M. Monoclonal 'internal image' anti-idiotypic antibodies of hepatitis B surface antigen. Immunology. 1985 Jun;55(2):197–204. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES